 | • レポートコード：D0-MOR-AP0184 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：健康管理 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、腸管理システムの世界市場について調査・分析した資料で、腸管理システムの市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
The bowel management systems market is anticipated to grow with a CAGR of 3.3%, during the forecast period. The significant factor attributing to the market’s growth is the rising incidence of inflammatory bowel diseases and increasing technological advancement. The increasing geriatric population across the globe is found to be more prone to constipation, diarrhea, and other bowel conditions that help to drive the bowel management systems market. It is also indicated in people with neurological disorders such as spinal cord injury, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, brain tumors, chronic constipation, and bedridden patients and children unable to pass stool regularly and properly. The effectiveness of bowel management systems stimulates the growth of the market.
Key Market Trends
Colostomy Bags segment is Expected to Hold the Largest Market Share in the Bowel Management Systems Market
Dominant share is retained by the colostomy bags segment owing to the attributes such as high incidence rates and health complications associated with Bowel. Diseases such as irritable bowel syndrome, multiple sclerosis, Crohn’s disease, and cancer are increasingly prevalent. In the near future, the broad spectrum of reasons for such conditions is projected to support development in the demand for colostomy bags.
Crohn’s disease is a form of inflammatory bowel disease (IBD) that can impact any portion from mouth-to-anus of the gastrointestinal tract which boosts the colostomy bag market. As per the Centers for Disease Control and Prevention (CDC), 1.0-1.3 million people suffer inflammatory bowel disease (IBD), while Crohn’s disease is more prevalent among smokers. While about 54,000 people and 17,000 women in the U.S. each year get bladder cancer as per the CDC (Centers for Disease Control and Prevention), which substantially increases the growth rate of the colostomy bags market.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to maintain its supremacy in the overall bowel management systems market, throughout the forecast period. This is owing to factors such as the rising prevalence of colorectal cancer and the growing geriatric population. However, according to the American Cancer Society, the colon cancer will be diagnosed in 51,690 men and 49,730 women in the United States in 2019. Colon cancer rates have increased in younger people. Colon cancer incidence rates rose from 1.0 percent to 2.4 percent annually in adults aged 20 to 39 years. Additionally, Increased patient awareness, rising adoption rates of intestinal management systems, excellently-established healthcare infrastructure and strong acceptance of developed products are also some of the key factors ensuring the dominance of the region.
Competitive Landscape
The bowel management systems market is highly competitive and consists of a few major players. In terms of market share, few of the major players are currently dominating the market. And some companies are vigorously making collaborations, acquisition, and launching new products with other companies to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Medtronic plc, Becton Dickinson and Company, B. Braun Melsungen AG, Coloplast Pty Ltd, and ConvaTec Inc.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Incidence of Inflammatory Bowel Disease
4.2.2 Rising Geriatric Population
4.3 Market Restraints
4.3.1 Patient’s Greater Preference for Non-invasive Treatment
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Colostomy Bags
5.1.2 Irrigation Systems
5.1.3 Nerve Modulation Devices
5.1.4 Others Products
5.2 By Patient Type
5.2.1 Adults
5.2.2 Paediatric
5.3 By End-User
5.3.1 Hospitals
5.3.2 Ambulatory Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic plc
6.1.2 Becton, Dickinson and Company
6.1.3 B. Braun Melsungen AG
6.1.4 Coloplast Pty Ltd
6.1.5 ConvaTec Group plc
6.1.6 Consure Medical Pvt. Ltd.
6.1.7 Cogentix Medical
6.1.8 Hollister Incorporated
6.1.9 ABC Medical Supply, Inc.
6.1.10 Laborie, Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS